Fingerprint
Dive into the research topics of 'Cabozantinib versus everolimus in advanced renal-cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cabozantinib versus everolimus in advanced renal-cell carcinoma
Toni K. Choueiri, Bernard Escudier, Thomas Powles, Paul N. Mainwaring, Brian I. Rini, Frede Donskov, Hans Hammers, Thomas E. Hutson, Jae Lyun Lee, Katriina Peltola, Bruce J. Roth, Georg A. Bjarnason, Lajos Geczi, Bhumsuk Keam, Pablo Maroto, Daniel Y.C. Heng, Manuela Schmidinger, Philip W. Kantoff, Anne Borgman-Hagey, Colin Hessel
Research output: Contribution to journal › Article › peer-review
977
Scopus
citations